Tentative Session Topics: JSRM Session Neural Stem Cells and Neurological Disorders Deconstructing and Reconstructing Organogenesis In-vitro Models of Health and Disease |
Costs and Benefits of Cell and Gene Therapies
Cell-based- and Immuno- Therapies STEMCELL Technologies Session - Organoids as Tools for Disease Modelling |
Currently Confirmed Speakers: Antonio BERTOLETTI Duke-NUS, Singapore Christopher BRAVERY Advbiols, UK Winston CHAN Genome Institute of Singapore, Singapore Louise CHENG Peter McCallum Cancer Centre, Australia Christine CHEUNG Lee Kong Chian School of Medicine, Singapore Ryan CONDER STEMCELL Technologies, Canada Ray DUNN Lee Kong Chian School of Medicine, Singapore Kim Jee GOH Lee Kong Chian School of Medicine, Singapore Javier GOMEZ FERNANDEZ Singapore University of Design & Technology Roger FOO Genome Institute of Singapore Damian HERNANDES DE SANTIAGO The University of Melbourne, Australia William HWANG National Cancer Centre, Singapore Masahiro KINO-OKA Osaka University, Japan Zeng LI National Neuroscience Institute, Singapore Jonathan LOH Institute of Molecular and Cell Biology, Singapore Sai Kiang LIM Institute of Molecular and Cell Biology, Singapore Yin LU Bioprocessing Technology Institute, Singapore Yin LU Bioprocessing Technology Institute, Singapore |
Yo MABUCHI
Tokyo Medical and Dental University, Japan Kyosuké MANO The Japanese Society for Regenerative Medicine, Japan Aiofe MURRAY Queen Mary University of London, UK Lisa NG Singapore Immunology Network Shi Yan NG Institute of Molecular and Cell Biology, Singapore Hideyuki OKANO Keio University, Japan Derrick ONG National University of Singapore Xinyi SU Institute of Molecular and Cell Biology, Singapore Alfred SUN Genome Institute of Singapore, Singapore Rica TANAKA Juntendo University, Japan Carol TANG National Neuroscience Institute, Singapore Adrian TEO Institute of Molecular and Cell Biology, Singapore Yuan QIANG Duke-NUS, Singapore Tom WYROBNIK University College London, UK Yun XIA Lee Kong Chian School of Medicine, Singapore Lei YE National Heart Centre, Singapore Jia ZHANG Novartis Pharmaceuticals Corporation, US |
Important Deadlines
Abstract submission deadline: 27 OCTOBER 2021 Submitted abstracts will be selected either for an oral or rapid fire talks. |
Online Registration closes:
29 November 2021 |
|
Registration fee includes
|
|